Joern Wulf

Summary

Country: Switzerland

Publications

  1. ncbi Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results
    Matthias Guckenberger
    Department of Radiation Oncology, University of Wurzburg, Wurzburg, Germany
    Radiat Oncol 4:67. 2009
  2. ncbi Stereotactic radiotherapy of primary liver cancer and hepatic metastases
    Joern Wulf
    Department of Radiotherapy, University of Wuerzburg, Josef Schneider Strasse 11, D 97080, Wuerzburg, Germany
    Acta Oncol 45:838-47. 2006
  3. ncbi Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation
    Matthias Guckenberger
    Department of Radiation Oncology, Julius Maximilians University, Wuerzburg, Germany
    Int J Radiat Oncol Biol Phys 74:47-54. 2009
  4. ncbi Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors
    Matthias Guckenberger
    Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany
    Acta Oncol 45:897-906. 2006
  5. ncbi Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer
    Matthias Guckenberger
    Department of Radiation Oncology, Julius Maximilians University, Wuerzburg, Germany
    Radiother Oncol 94:53-9. 2010
  6. ncbi Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study
    Matthias Guckenberger
    Department of Radiation Oncology, Julius Maximilians University, Josef Schneider Strasse 11, Wuerzburg, Germany
    Radiother Oncol 85:435-42. 2007
  7. ncbi Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients
    Joern Wulf
    Department of Radiotherapy, University of Wuerzburg, Josef Schneider Strasse 11, D 97080 Wuerzburg, Germany
    Int J Radiat Oncol Biol Phys 60:186-96. 2004
  8. ncbi Dose-response in stereotactic irradiation of lung tumors
    Joern Wulf
    Department of Radiotherapy, University of Wuerzburg, Wuerzburg, Germany
    Radiother Oncol 77:83-7. 2005
  9. ncbi Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets
    Ulrich Haedinger
    Department of Radiotherapy, University of Wuerzburg, Wuerzburg, Germany
    Int J Radiat Oncol Biol Phys 61:239-49. 2005
  10. ncbi Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial
    Juergen Dunst
    Department of Radiotherapy, University of Lubeck, Lubeck, Germany
    Strahlenther Onkol 184:450-6. 2008

Collaborators

Detail Information

Publications10

  1. ncbi Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results
    Matthias Guckenberger
    Department of Radiation Oncology, University of Wurzburg, Wurzburg, Germany
    Radiat Oncol 4:67. 2009
    ..To evaluate clinical outcome after preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy and adjuvant chemotherapy for pathological stage UICC >or= II...
  2. ncbi Stereotactic radiotherapy of primary liver cancer and hepatic metastases
    Joern Wulf
    Department of Radiotherapy, University of Wuerzburg, Josef Schneider Strasse 11, D 97080, Wuerzburg, Germany
    Acta Oncol 45:838-47. 2006
    ..Patient selection is important, because those with low risk for systemic progression are more likely to benefit from this approach...
  3. ncbi Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation
    Matthias Guckenberger
    Department of Radiation Oncology, Julius Maximilians University, Wuerzburg, Germany
    Int J Radiat Oncol Biol Phys 74:47-54. 2009
    ..To evaluate outcome after image-guided stereotactic body radiotherapy (SBRT) for early-stage non-small-cell lung cancer (NSCLC) and pulmonary metastases...
  4. ncbi Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors
    Matthias Guckenberger
    Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany
    Acta Oncol 45:897-906. 2006
    ..5 mm vs 1.4 mm). Image-guidance using CB-CT was validated for high precision radiotherapy of intrapulmonary tumors. It was shown that both the planning reference and the verification image study have to consider tumor breathing motion...
  5. ncbi Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer
    Matthias Guckenberger
    Department of Radiation Oncology, Julius Maximilians University, Wuerzburg, Germany
    Radiother Oncol 94:53-9. 2010
    ..To evaluate outcome of radiotherapy for locally recurrent cervical and endometrial cancer...
  6. ncbi Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study
    Matthias Guckenberger
    Department of Radiation Oncology, Julius Maximilians University, Josef Schneider Strasse 11, Wuerzburg, Germany
    Radiother Oncol 85:435-42. 2007
    ..To evaluate the CT morphological pattern of tumor response and pulmonary injury after stereotactic body radiotherapy (SBRT) for early stage non-small lung cancer (NSCLC) and pulmonary metastases...
  7. ncbi Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients
    Joern Wulf
    Department of Radiotherapy, University of Wuerzburg, Josef Schneider Strasse 11, D 97080 Wuerzburg, Germany
    Int J Radiat Oncol Biol Phys 60:186-96. 2004
    ..The clinical results of dose escalation using stereotactic radiotherapy to increase local tumor control in medically inoperable patients with Stage I-II non-small-cell lung cancer or pulmonary metastases were evaluated...
  8. ncbi Dose-response in stereotactic irradiation of lung tumors
    Joern Wulf
    Department of Radiotherapy, University of Wuerzburg, Wuerzburg, Germany
    Radiother Oncol 77:83-7. 2005
    ..Multivariate analysis revealed the dose at the PTV-margin as the only significant factor for local control...
  9. ncbi Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets
    Ulrich Haedinger
    Department of Radiotherapy, University of Wuerzburg, Wuerzburg, Germany
    Int J Radiat Oncol Biol Phys 61:239-49. 2005
    ..To compare the pencil beam (PB) and collapsed cone (CC)-based three-dimensional dose calculation used for stereotactic irradiation of pulmonary targets...
  10. ncbi Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial
    Juergen Dunst
    Department of Radiotherapy, University of Lubeck, Lubeck, Germany
    Strahlenther Onkol 184:450-6. 2008
    ..The objective of this expanded phase II trial was to confirm the safety results of the preceding phase I study and establish the efficacy of neoadjuvant radiochemotherapy with capecitabine in rectal cancer in a multicenter setting...